T1	Outcomes 44 69	EFficacy and tolerability
T2	Outcomes 204 248	low-density lipoprotein cholesterol (LDL-C).
T3	Outcomes 272 316	high-density lipoprotein cholesterol (HDL-C)
T4	Outcomes 450 455	LDL-C
T5	Outcomes 829 856	efficacy and safety profile
T6	Outcomes 1063 1068	LDL-C
T7	Outcomes 1283 1368	percent change from baseline in LDL-C and the safety and tolerability of anacetrapib.
T8	Outcomes 1536 1568	blood pressure and electrolytes.
T9	Outcomes 1848 1902	Lipid results, clinical CV events, and safety outcomes
